SensoDetect specialises in the development of equipment used to analyse the reaction of sound stimulus in the brain of a patient. The technology is mainly used in psychiatry when treating patients to distinguish potential mental disorders. The product consists of electrodes that are attached to the head of the patient to analyse brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Thomas Erik Frithiof Holmgren | 11,86 | 11,86 | 2024-06-26 |
| QQM Fund Management AB | 9,57 | 9,57 | 2024-08-31 |
| Nordnet Pensionsförsäkring | 8,87 | 8,87 | 2024-06-26 |
| Avanza Pension | 4,79 | 4,79 | 2024-06-26 |
| Karl Vilhelm Gustaf Lundin | 3,70 | 3,70 | 2024-06-26 |
| Tore Robertsson | 3,13 | 3,13 | 2024-06-26 |
| Johan Möllerström med bolag | 2,81 | 2,81 | 2024-06-26 |
| Per-Anders Hedin | 2,62 | 2,62 | 2024-09-03 |
| Birgitta Möllerström | 2,21 | 2,21 | 2024-06-26 |
| Scandinavian Medicon Invest AB | 1,82 | 1,82 | 2024-06-26 |
2024-11-08 Delårsrapport 2024-Q3
2025-02-21 Bokslutskommuniké 2024
2025-05-23 Årsstämma 2024
